キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/02 | 2,091 | 2,100 | 2,059 | 2,086 | -5 | -0.2% | 78,200 |
2021/06/01 | 2,102 | 2,104 | 2,070 | 2,091 | -26 | -1.2% | 111,300 |
2021/05/31 | 2,140 | 2,168 | 2,108 | 2,117 | -22 | -1% | 87,500 |
2021/05/28 | 2,104 | 2,139 | 2,098 | 2,139 | +59 | +2.8% | 111,000 |
2021/05/27 | 2,096 | 2,118 | 2,080 | 2,080 | -16 | -0.8% | 107,500 |
2021/05/26 | 2,101 | 2,115 | 2,091 | 2,096 | -20 | -0.9% | 67,800 |
2021/05/25 | 2,100 | 2,138 | 2,100 | 2,116 | +1 | ±0% | 68,200 |
2021/05/24 | 2,119 | 2,138 | 2,097 | 2,115 | +15 | +0.7% | 61,900 |
2021/05/21 | 2,112 | 2,124 | 2,093 | 2,100 | -21 | -1% | 57,400 |
2021/05/20 | 2,111 | 2,134 | 2,108 | 2,121 | +10 | +0.5% | 45,700 |
2021/05/19 | 2,095 | 2,118 | 2,086 | 2,111 | -17 | -0.8% | 69,400 |
2021/05/18 | 2,133 | 2,136 | 2,120 | 2,128 | -4 | -0.2% | 60,000 |
2021/05/17 | 2,109 | 2,140 | 2,109 | 2,132 | +23 | +1.1% | 85,800 |
2021/05/14 | 2,079 | 2,133 | 2,079 | 2,109 | +60 | +2.9% | 106,000 |
2021/05/13 | 2,086 | 2,103 | 2,026 | 2,049 | -42 | -2% | 129,500 |
2021/05/12 | 2,187 | 2,200 | 2,089 | 2,091 | -164 | -7.3% | 161,400 |
2021/05/11 | 2,299 | 2,310 | 2,251 | 2,255 | -43 | -1.9% | 87,700 |
2021/05/10 | 2,285 | 2,304 | 2,283 | 2,298 | +30 | +1.3% | 44,800 |
2021/05/07 | 2,256 | 2,281 | 2,255 | 2,268 | +24 | +1.1% | 59,800 |
2021/05/06 | 2,254 | 2,287 | 2,244 | 2,244 | +26 | +1.2% | 74,000 |
2021/04/30 | 2,225 | 2,246 | 2,212 | 2,218 | +3 | +0.1% | 76,500 |
2021/04/28 | 2,240 | 2,243 | 2,215 | 2,215 | -22 | -1% | 77,800 |
2021/04/27 | 2,249 | 2,260 | 2,234 | 2,237 | -31 | -1.4% | 80,900 |
2021/04/26 | 2,333 | 2,333 | 2,268 | 2,268 | -15 | -0.7% | 95,200 |
2021/04/23 | 2,288 | 2,302 | 2,271 | 2,283 | -28 | -1.2% | 60,600 |
2021/04/22 | 2,290 | 2,324 | 2,281 | 2,311 | +54 | +2.4% | 61,800 |
2021/04/21 | 2,267 | 2,282 | 2,249 | 2,257 | -39 | -1.7% | 93,600 |
2021/04/20 | 2,320 | 2,321 | 2,290 | 2,296 | -52 | -2.2% | 71,900 |
2021/04/19 | 2,360 | 2,376 | 2,343 | 2,348 | -27 | -1.1% | 47,100 |
2021/04/16 | 2,395 | 2,397 | 2,367 | 2,375 | -9 | -0.4% | 36,600 |
2021/04/15 | 2,381 | 2,391 | 2,363 | 2,384 | +18 | +0.8% | 36,600 |
2021/04/14 | 2,374 | 2,375 | 2,342 | 2,366 | +15 | +0.6% | 67,600 |
2021/04/13 | 2,377 | 2,410 | 2,348 | 2,351 | -32 | -1.3% | 78,800 |
2021/04/12 | 2,375 | 2,397 | 2,350 | 2,383 | +51 | +2.2% | 69,600 |
2021/04/09 | 2,337 | 2,375 | 2,332 | 2,332 | +13 | +0.6% | 58,000 |
2021/04/08 | 2,342 | 2,369 | 2,314 | 2,319 | -59 | -2.5% | 88,800 |
2021/04/07 | 2,379 | 2,395 | 2,360 | 2,378 | +7 | +0.3% | 60,500 |
2021/04/06 | 2,389 | 2,418 | 2,352 | 2,371 | -27 | -1.1% | 75,300 |
2021/04/05 | 2,425 | 2,434 | 2,381 | 2,398 | -36 | -1.5% | 64,500 |
2021/04/02 | 2,474 | 2,474 | 2,425 | 2,434 | -19 | -0.8% | 46,300 |
2021/04/01 | 2,500 | 2,501 | 2,429 | 2,453 | +3 | +0.1% | 84,400 |
2021/03/31 | 2,472 | 2,499 | 2,450 | 2,450 | -90 | -3.5% | 107,900 |
2021/03/30 | 2,594 | 2,594 | 2,515 | 2,540 | -70 | -2.7% | 99,900 |
2021/03/29 | 2,593 | 2,620 | 2,570 | 2,610 | +23 | +0.9% | 113,300 |
2021/03/26 | 2,609 | 2,616 | 2,570 | 2,587 | +28 | +1.1% | 97,200 |
2021/03/25 | 2,584 | 2,585 | 2,539 | 2,559 | +6 | +0.2% | 97,400 |
2021/03/24 | 2,599 | 2,635 | 2,529 | 2,553 | -66 | -2.5% | 116,500 |
2021/03/23 | 2,685 | 2,734 | 2,613 | 2,619 | -109 | -4% | 206,400 |
2021/03/22 | 2,600 | 2,790 | 2,587 | 2,728 | +257 | +10.4% | 349,200 |
2021/03/19 | 2,421 | 2,476 | 2,414 | 2,471 | +75 | +3.1% | 522,300 |
1051~
1100
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム